Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,958 | 25 | 95.2% |
| Education | $98.55 | 2 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $785.74 | 10 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $388.81 | 4 | $0 (2021) |
| Biogen, Inc. | $164.29 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $125.00 | 1 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $125.00 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $121.62 | 1 | $0 (2022) |
| Eisai Inc. | $95.25 | 1 | $0 (2021) |
| Kyowa Kirin, Inc. | $94.52 | 1 | $0 (2024) |
| ABBVIE INC. | $93.33 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $33.83 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $327.97 | 5 | Otsuka America Pharmaceutical, Inc. ($125.00) |
| 2022 | $393.97 | 5 | Neurocrine Biosciences, Inc. ($129.22) |
| 2021 | $1,334 | 17 | Neurocrine Biosciences, Inc. ($656.52) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Kyowa Kirin, Inc. | — | Food and Beverage | In-kind items and services | $94.52 | General |
| 09/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Bone Health | ||||||
| 04/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 04/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.33 | General |
| 03/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/16/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Neuropsychiatry | ||||||
| 06/08/2022 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: CNS | ||||||
| 05/24/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Neuropsychiatry | ||||||
| 04/19/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 02/22/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $121.62 | General |
| Category: PRIMARY CARE | ||||||
| 10/19/2021 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $81.28 | General |
| 10/12/2021 | Neurocrine Biosciences, Inc. | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $112.36 | General |
| Category: NEUROLOGY | ||||||
| 09/30/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $119.34 | General |
| Category: PRIMARY CARE | ||||||
| 07/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $92.52 | General |
| Category: PRIMARY CARE | ||||||
| 07/21/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $121.69 | General |
| Category: NEUROLOGY | ||||||
| 06/23/2021 | Neurocrine Biosciences, Inc. | ONGENTYS (Drug), INGREZZA | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: NEUROLOGY | ||||||
| 06/21/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/09/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $126.35 | General |
| Category: NEUROLOGY | ||||||
| 05/20/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROLOGY | ||||||
| 05/20/2021 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $83.01 | General |
| 05/18/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: PRIMARY CARE | ||||||
| 05/05/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CNS | ||||||
| 03/24/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $69.00 | General |
| Category: PRIMARY CARE | ||||||
| 03/16/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $95.25 | General |
| Category: Neurology | ||||||
| 02/05/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Education | In-kind items and services | $62.60 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 248 | 679 | $99,700 | $27,071 |
| 2022 | 3 | 257 | 742 | $97,540 | $31,922 |
| 2021 | 1 | 171 | 434 | $86,800 | $35,207 |
| 2020 | 2 | 104 | 209 | $40,780 | $17,583 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 184 | 520 | $52,000 | $15,976 | 30.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 64 | 159 | $47,700 | $11,094 | 23.3% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 82 | 203 | $40,600 | $16,717 | 41.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 138 | 444 | $44,400 | $10,781 | 24.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 95 | $12,540 | $4,425 | 35.3% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 171 | 434 | $86,800 | $35,207 | 40.6% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 84 | 189 | $37,800 | $16,987 | 44.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 20 | $2,980 | $595.78 | 20.0% |
About Christine Rohl
Christine Rohl is a Family healthcare provider based in Munster, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083668909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christine Rohl has received a total of $2,056 in payments from pharmaceutical and medical device companies, with $327.97 received in 2024. These payments were reported across 27 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,958).
As a Medicare-enrolled provider, Rohl has provided services to 780 Medicare beneficiaries, totaling 2,064 services with total Medicare billing of $111,783. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Munster, IN
- Active Since 05/22/2006
- Last Updated 07/09/2007
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1083668909
Products in Payments
- INGREZZA (Drug) $564.86
- NURTEC ODT (Drug) $510.43
- ONGENTYS (Drug) $220.88
- Crysvita (Drug) $125.00
- REXULTI (Drug) $125.00
- Fycompa (Drug) $95.25
- APTIOM (Drug) $33.83
- EVENITY (Biological) $15.12
- BOTOX (Biological) $13.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Munster
Mrs. Monika Vasic, Fnp, FNP
Family — Payments: $18,565
Sharon Henn, Np-C, NP-C
Family — Payments: $15,250
Donna Winterrowd
Family — Payments: $14,869
Mrs. Jacquelyn Adley, Np-C, NP-C
Family — Payments: $12,999
Lisa Poradzisz
Family — Payments: $10,254
Marissa Bottos, Fnp, Aprn, FNP, APRN
Family — Payments: $10,062